TOP TIERMARKET NEWSWIRE
News & sentiment

SUMMIT THERAPEUTICS (SMMT) — News & AI sentiment

SUMMIT THERAPEUTICS (SMMT) news roundup. 7 stories in the past week, 41 over 30 days. Average 30-day sentiment is 61.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
7
avg sentiment 62.7/100
30d stories
41
avg sentiment 61.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

SMMT news in the last 24 hours, 7 days, 30 days and 90 days

How much SMMT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowSMMT storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days762.7/100SMMT headlines →
Last 30 days4161.7/100SMMT headlines →
Last 90 days9157.7/100SMMT headlines →

Latest stories on SMMT

4d ago
Summit Therapeutics stock surges on Jefferies upgrade to buy
Investing.com Markets61 · neutralanalyst
4d ago
Jefferies upgrades Summit Therapeutics stock rating on trial outlook
Investing.com Analyst Ratings61 · neutralanalyst
4d ago
4d ago
4d ago
UBS reiterates Buy on Summit Therapeutics stock, $33 target
Investing.com Analyst Ratings61 · neutralanalyst
5d ago
6d ago
Sep 3
Sep 3
Sep 3
Sep 3
Sep 3
Sep 3
Summit Therapeutics stock rises on positive survival data
Investing.com Markets63 · neutralproduct/pr
Sep 3
Sep 3
Sep 2
Cantor Fitzgerald reiterates Summit Therapeutics stock rating
Investing.com Analyst Ratings50 · neutralanalyst
Sep 1
Aug 27
Aug 27
Aug 26
Aug 26
Aug 26
Aug 26
Aug 26
Aug 26
Open SMMT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →